686 related articles for article (PubMed ID: 17881141)
1. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
2. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor--correlation with biopsy findings.
Rouvière O; Valette O; Grivolat S; Colin-Pangaud C; Bouvier R; Chapelon JY; Gelet A; Lyonnet D
Urology; 2004 May; 63(5):922-7. PubMed ID: 15134982
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
4. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.
Moman MR; van den Berg CA; Boeken Kruger AE; Battermann JJ; Moerland MA; van der Heide UA; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):741-6. PubMed ID: 19804948
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
[TBL] [Abstract][Full Text] [Related]
7. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection.
Morgan VA; Kyriazi S; Ashley SE; DeSouza NM
Acta Radiol; 2007 Jul; 48(6):695-703. PubMed ID: 17611881
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
[TBL] [Abstract][Full Text] [Related]
12. Description of magnetic resonance imaging-derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions.
Zelhof B; Lowry M; Rodrigues G; Kraus S; Turnbull L
BJU Int; 2009 Sep; 104(5):621-7. PubMed ID: 19281464
[TBL] [Abstract][Full Text] [Related]
13. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Taupitz M; Böhmer D; Beyersdorff D
Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
[TBL] [Abstract][Full Text] [Related]
14. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
[TBL] [Abstract][Full Text] [Related]
15. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
[TBL] [Abstract][Full Text] [Related]
16. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
[TBL] [Abstract][Full Text] [Related]
17. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
18. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.
Wefer AE; Hricak H; Vigneron DB; Coakley FV; Lu Y; Wefer J; Mueller-Lisse U; Carroll PR; Kurhanewicz J
J Urol; 2000 Aug; 164(2):400-4. PubMed ID: 10893595
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer.
Kayhan A; Fan X; Oto A
Top Magn Reson Imaging; 2009 Apr; 20(2):105-12. PubMed ID: 20010065
[TBL] [Abstract][Full Text] [Related]
20. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology.
Kozlowski P; Chang SD; Jones EC; Berean KW; Chen H; Goldenberg SL
J Magn Reson Imaging; 2006 Jul; 24(1):108-13. PubMed ID: 16767709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
